ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

CCOP RFA Due In Mid-July; DCT Board Gives Its Concept Approval

June 11, 1982

Grants Funding; NCI Restores Paylines To Last Year’s Levels

July 4, 1997

Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years

April 25, 2014

USC Scientists Says It’s Time Nobelists Recognize Value of Cancer Program

February 10, 1978

Grantees Seek $433.5 Million for construction

November 17, 1978